Thrombotic Risk Determined by STAB 2 Variants in a Population-Based Cohort Study

Circ Genom Precis Med. 2021 Oct;14(5):e003449. doi: 10.1161/CIRCGEN.121.003449. Epub 2021 Aug 31.

Collaborators

Regeneron Genetics Center*:
Goncalo Abecasis, Michael Cantor, Giovanni Coppola, John D Overton, Jeffrey G Reid, Alan Shuldiner, Katia Karalis, Katherine Siminovitch, Christina Beechert, Caitlin Forsythe, Erin D Fuller, Zhenhua Gu, Michael Lattari, Alexander Lopez, John D Overton, Thomas D Schleicher, Maria Sotiropoulos Padilla, Louis Widom, Sarah E Wolf, Manasi Pradhan, Kia Manoochehri, Ricardo H Ulloa, Xiaodong Bai, Suganthi Balasubramanian, Andrew Blumenfeld, Boris Boutkov, Gisu Eom, Lukas Habegger, Alicia Hawes, Shareef Khalid, Olga Krasheninina, Rouel Lanche, Adam J Mansfield, Evan K Maxwell, Mrunali Nafde, Sean O'Keeffe, Max Orelus, Razvan Panea, Tommy Polanco, Ayesha Rasool, Jeffrey G Reid, William Salerno, Jeffrey C Staples, Niek Verweij, Jonas Nielsen, Tanima De, Marcus B Jones, Jason Mighty, Michelle G LeBlanc, Lyndon J Mitnaul

Affiliations

¹ Department of Environmental Science and Bioscience, Kristianstad University, Kristianstad (E.M., C.H., C.L.-H.).
² Department of Clinical Sciences, Lund University, Skåne University Hospital, Malmö, Sweden (J.E., P.J.S., G.E., O.M.).
³ Regeneron Genetics Center, Tarrytown, NY (A.B., L.A.L.).
⁴ Center for Primary Health Care Research, Lund University & Region Skåne, Malmö, Sweden (B.Z.).

PMID: 34461736
DOI: 10.1161/CIRCGEN.121.003449

No abstract available

Keywords: genetics; population; risk; thrombosis; venous thromboembolism.

Publication types

Letter
Comment

MeSH terms

Cohort Studies*
Humans
Risk Factors